RYTHM, Inc. RYM
mean RYTHM, Inc. and its subsidiaries on a consolidated basis.
Corporation) (together with its subsidiaries, the "Company" or "RYTHM") delivers well-being to consumers through
its portfolio of hemp-derived tetrahydrocannabinol ("hemp-derived THC") products and iconic licensed brands. The Company's
portfolio of consumer-packaged goods brands includes RYTHM, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon's, Good
Last close
15.69
2026-10-23
Market cap
$34.2M
2026-06-30 share count
52-week range
14.00 - 50.38
Valuation FY2025 figures against the last close
P/S2.0x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-16.68
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $17.3M | $18.0K | $15.1M | $58.3M | $59.9M | $12.1M | — |
| Cost of revenue | $7.1M | $89.0K | $11.1M | $90.1M | $54.6M | $11.5M | — |
| Gross profit | $10.2M | -$71.0K | $4.0M | -$31.8M | $5.2M | $570.0K | — |
| R&D | — | $743.0K | $2.3M | $8.2M | $3.9M | $3.4M | — |
| SG&A | $34.1M | $7.2M | $11.5M | $73.4M | $30.8M | $9.8M | — |
| Total operating expenses | $42.5M | $5.0M | $10.2M | $161.5M | $40.3M | $13.2M | — |
| Operating income | -$32.3M | -$5.1M | -$10.2M | -$193.3M | -$35.1M | -$12.6M | — |
| Interest expense | $4.1M | $156.0K | $2.1M | $8.8M | $74.0K | $481.0K | — |
| Pre-tax income | -$34.7M | -$23.2M | -$11.9M | -$188.3M | -$32.3M | -$21.6M | — |
| Income tax | — | $2.0K | $2.0K | $23.0K | $25.0K | — | — |
| Net income | -$33.3M | -$41.7M | -$18.6M | -$188.2M | -$32.5M | -$21.6M | — |
| EPS, basic | -16.68 | -40.92 | -187.64 | -902.19 | -1.69 | -5.32 | — |
| EPS, diluted | -16.68 | -40.92 | -187.64 | -902.19 | -1.69 | -5.32 | — |
| Shares, diluted (wtd. avg.) | 2.0M | 1.0M | 99,391 | 208,573 | 95,455 | 4.2M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $32.2M | $31.2M | $434.0K | $10.5M | $12.0M | $8.1M | $206.0K |
| Short-term investments | — | — | $4.0K | $460.0K | $44.5M | — | — |
| Receivables | $9.3M | $30.0K | $855.0K | $1.1M | $7.2M | $4.0M | — |
| Inventory | $4.0M | $500.0K | $5.0M | $21.4M | $20.5M | $5.2M | — |
| Total current assets | $47.5M | $34.7M | $24.0M | $44.9M | $86.7M | $18.6M | — |
| Property, plant and equipment | — | $186.0K | $595.0K | $10.0M | $6.2M | $873.0K | — |
| Goodwill | $9.7M | $9.7M | — | — | $50.1M | $632.0K | — |
| Other intangibles | — | $8.9M | — | — | $14.1M | $1.7M | — |
| Total assets | $106.7M | $54.0M | $45.3M | $69.7M | $182.0M | $21.8M | — |
| Accounts payable | $2.3M | $825.0K | $4.4M | $20.5M | $9.2M | $693.0K | — |
| Short-term debt | $3.6M | $522.0K | $766.0K | $28.8M | $1.1M | — | — |
| Total current liabilities | $43.0M | $24.7M | $41.2M | $70.6M | $43.6M | $27.0M | — |
| Long-term debt | $5.0M | $1.0K | $16.0M | $407.0K | $12.0K | $829.0K | — |
| Total liabilities | $93.7M | $25.9M | $60.0M | $78.7M | $44.6M | $28.3M | — |
| Retained earnings | -$340.8M | -$307.3M | -$265.8M | -$247.1M | -$59.0M | -$26.5M | — |
| Total equity | $13.0M | $28.1M | -$14.7M | -$9.0M | $137.4M | -$6.5M | -$805.0K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$23.5M | -$11.6M | -$31.0M | -$72.0M | -$30.1M | -$14.8M | — |
| Depreciation and amortisation | — | $300.0K | $700.0K | $1.7M | $655.0K | $188.0K | — |
| Stock-based compensation | $2.2M | $1.2M | $2.7M | $4.3M | — | — | — |
| Capital expenditure | — | $4.0K | $59.0K | $8.1M | $2.2M | $136.0K | — |
| Investing cash flow | -$55.1M | -$54.0K | $25.2M | -$2.3M | -$104.7M | -$1.2M | — |
| Financing cash flow | $79.7M | $42.4M | -$4.2M | $72.8M | $138.8M | $23.9M | — |
| Dividends paid | — | — | — | — | $61.0K | $583.0K | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-023069.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | $12.1M | $59.9M | $58.3M | $15.1M | $18.0K | $17.3M |
| Gross profit | — | $570.0K | $5.2M | -$31.8M | $4.0M | -$71.0K | $10.2M |
| Net income | — | -$21.6M | -$32.5M | -$188.2M | -$18.6M | -$41.7M | -$33.3M |
Recent filings and events
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
- Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
- Change of control Control of the company has changed hands. Item 5.01
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Shareholder vote Item 5.07
- Results announced Item 2.02
- Material agreement signed Item 1.01
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 0700
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| AVO | Mission Produce, Inc. | $1.03B | 22.1x | 12.7% |
| BV | BrightView Holdings, Inc. | $980.6M | 81.5x | -3.4% |
| BNC | CEA Industries Inc. | $229.1M | — | — |
| PFAI | Pinnacle Food Group Ltd | — | — | 3.7% |